FFRct

HeartFlow, Inc · K182035 · 2018-12-06

FFRct is an AI-enabled medical device from HeartFlow, Inc, listed by FDA (510(k), K182035) with a decision date of 2018-12-06. Review panel: Cardiovascular.

FDA submission numberK182035
Pathway510(k)
CompanyHeartFlow, Inc
Review panel (specialty)Cardiovascular
FDA decision date2018-12-06
DecisionSubstantially Equivalent
Product codePJA
ClassificationCoronary Vascular Physiologic Simulation Software
Device class2
Regulation number870.1415
Review time (calendar days)129
Applicant countryUS

Official FDA database record · FDA AI-enabled device list

More devices from HeartFlow, Inc · All Cardiovascular AI devices · Full device index

Data from FDA's AI-enabled device list and openFDA. Informational only; verify against the FDA record.